"These results indicate that the sMICA level may be associated with the prognosis of patients with prostate cancer. This work represents an advance in biomedical science because it shows that sMICA and EOD(Extend of Disease) are both prognostic factors that can be used to identify patients with a poor prognosis who may benefit from more aggressive management"xsd:string